Previous clinical studies evaluating the relationship between serum VEGF and the SII and SCLC are limited and mainly involve the prediction of prognosis, some of which are controversial 13-17, and few studies have evaluated the predictive value of the treatment efficacy of VEGF and the SII. Here, VEGFA is linked to small cell lung carcinoma.